← All diseases
Muscles and connective tissue
Severe myasthenia gravis
Would you like to receive a message when there is new research on Severe myasthenia gravis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll see one sentence explaining what was researched — and you'll be notified as soon as there is new research on Severe myasthenia gravis. View what Premium costs.
Publications and studies (1467)
- Investigating and validating the molecular mechanisms of lipid metabolism regulation in myasthenia gravis development based on single-cell, bulk transcriptomics, and RT-qPCR. (2026/12/31) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Hospital resource utilization in patients with generalized myasthenia gravis treated with nipocalimab: results from the VIVACITY-MG3 study. (2026/12/01) ♡
- Early use of low dose rituximab in anti acetylcholine receptor generalized myasthenia gravis in South Wales - A retrospective study. (2026/10/15) ♡
- Rituximab in AChR and MusK Myasthenia Gravis: long-term follow-up with different therapeutic protocols. (2026/10/15) ♡
- Thymectomy promotes maintained complete stable remission in myasthenia gravis. (2026/10/01) ♡
- Diabetes mellitus exacerbates myasthenia gravis by upregulating CD40 expression on B cells through the RAGE-HIF-1α-HK2 pathway. (2026/10/01) ♡
- Rate of Autoimmune Diseases in the 10 Years Preceding Myasthenia Gravis Diagnosis: A Nationwide Cohort Study in South Korea. (2026/09/08) ♡
- Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry. (2026/08/11) ♡
- Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis. (2026/08/11) ♡
- Management of Exacerbations and Rescue Therapy: A Prespecified Analysis of the Phase 3 Myasthenia Gravis Inebilizumab Randomized Clinical Trial. (2026/08/10) ♡
- Clinicopathological profile and treatment outcomes of advanced/unresectable thymic malignancies from a tertiary care centre in India. (2026/08/07) ♡
- High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies. (2026/08/04) ♡
- Prospective study of efgartigimod in severe myasthenia gravis exacerbations requiring ventilatory or enteral support. (2026/08/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Comprehensive Care Goals in Myasthenia Gravis: Expert Consensus Recommendations Using the RAND/UCLA Appropriateness Method. (2026/08/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Double trouble following VATS thymectomy for thymoma: an unusual complication and new-onset myasthenia gravis in the follow-up period. (2026/08/01) ♡
- Long-Term Cancer and Mortality After Thymectomy. (2026/08/01) ♡
- Unexpected longevity in myasthenia gravis: a multi-state population-based comparison with multiple sclerosis and the U.S. population. (2026/08/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Comment on "Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis". (2026/07/31) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Response to the comment on "Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis". (2026/07/31) ♡
- South African Flag Sign in Contrast-Induced Kounis Syndrome: When the Flag Misleads. (2026/07/30) ♡
- Exploring the Value of Quantitative Muscle Ultrasound in Neuromuscular Junction Disorders: A Pilot Study. (2026/07/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pediatric Extrapolation in Neuropsychiatric Drug Development: Leveraging Pharmacokinetic and Pharmacodynamic Strategies to Facilitate FDA Approvals. (2026/07/30) ♡
- Identification of PTGS2 as a genetically supported protective biomarker and potential therapeutic target in myasthenia gravis. (2026/07/30) ♡
- Terminal complement inhibition is associated with renal, hematologic, and thrombotic complications during septic shock: A global propensity score-matched cohort study. (2026/07/29) ♡
- Unusual Sequential Development of Multiple Sclerosis, Thymoma, Myasthenia, and Lymphoma in the Same Patient. (2026/07/29) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Beyond muscle weakness: Expanding the therapeutic horizon of thymectomy in myasthenia gravis. (2026/07/29) ♡
- Myasthenia gravis: Diagnostic journey and therapeutic outcomes in patients followed at a Brazilian public tertiary center - A retrospective cohort study. (2026/07/28) ♡
- Bisphenol A exposure in myasthenia gravis: Potential targets and mechanisms revealed by network toxicology and molecular dynamics. (2026/07/28) ♡
- Mismatch Between the Distribution of Neuromuscular Specialists and Myasthenia Gravis Patients in the US Medicare Fee-for-Service Population. (2026/07/27) ♡
- Gefurulimab-The First Effective Nanobody in Myasthenia Gravis Therapy. (2026/07/27) ♡
- Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. (2026/07/27) ♡
- Postoperative Complications Following Spine Surgery in Myasthenia Gravis Patients: A Propensity-Matched National Database Analysis. (2026/07/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. CAR-based cellular therapies for autoimmune diseases: immune reset, clinical evidence, and translational boundaries. (2026/07/27) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Thymectomy in myasthenia gravis: timing and indications. (2026/07/25) ♡
- Clinical efficacy and cost per improved outcome of treatments for generalized myasthenia gravis: evidence from a network meta-analysis and cost-per-responder analysis. (2026/07/24) ♡
- Data-augmented machine learning refines the effective-concentration estimate for eculizumab in complement-mediated diseases. (2026/07/24) ♡
- Association of therapeutic plasma exchange with functional outcomes in selected neurological disorders: a retrospective cohort study from a single tertiary center in Saudi Arabia. (2026/07/21) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cystic Thymoma-Associated Fulminant Myasthenia Gravis with Rapid Progression in a Cat: Diagnostic and Therapeutic Challenges. (2026/07/20) ♡
- A multi-dimensional phenotyping framework reveals coordinated neuromuscular, immune, and imaging-derived phenotypes in experimental autoimmune myasthenia gravis. (2026/07/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Efgartigimod: a beacon of hope for overlapping stiff-person syndrome and myasthenia gravis following thymoma. (2026/07/20) ♡
- Congenital myasthenic syndromes in a Southeast Asian adult neurology clinic: a long road to diagnosis and therapy. (2026/07/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Improving outcomes in myasthenia gravis: uni-portal video-assisted thoracoscopic (UVATS) thymectomy in a single-centre retrospective cohort. (2026/07/17) ♡
- Patient Communication Outside of Visits: Implications for Remote Monitoring and Digital Care Models in Myasthenia Gravis. (2026/07/16) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Very late-onset myasthenia gravis: a systematic review and meta-analysis of sex distribution, thymic pathology and autoantibodies. (2026/07/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Neoadjuvant chemotherapy enabling resection of stage IVA thymoma with myasthenia gravis and systemic lupus erythematosus: a case report. (2026/07/16) ♡
- Anti-C2-mediated complement inhibition prevents disease in a rat passive transfer model of myasthenia gravis. (2026/07/16) ♡
- Assessing Efgartigimod (VYVGART™) Social Media Posts in Generalized Myasthenia Gravis to Understand Patient, Caregiver, and Health Care Professional Sentiments. (2026/07/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Idiopathic Orbital Inflammation Masquerading as Relapse of Seronegative Juvenile Myasthenia Gravis: A Case Report. (2026/07/15) ♡
- Perioperative Administration of Efgartigimod in myasthenia gravis patients with Thymoma: A six-case series. (2026/07/15) ♡
- Targeting BLyS and APRIL with Telitacicept versus Conventional Immunotherapy in Generalized Myasthenia Gravis: A Comparative Study. (2026/07/15) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.